Latest DEF 14A proxy statements

Arvinas, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 24, 2026, to elect directors, vote on executive compensation, and ratify auditor appointment.

Datadog, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 15, 2026, detailing proposals for director elections, executive compensation, auditor ratification, and a stockholder proposal.

OFS Capital Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026, detailing proposals for director elections and auditor ratification.

International Seaways, Inc. has announced its Annual Meeting of Stockholders will be held on June 8, 2026, with a hybrid in-person and virtual format.

Heartflow, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect directors and ratify the appointment of its independent auditor.

John Marshall Bancorp, Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for June 16, 2026, detailing proposals for director elections and auditor ratification.

Shoulder Innovations, Inc. invites stockholders to its 2026 Annual Meeting on June 26, 2026, to elect directors and ratify auditor appointment.

Citizens Community Bancorp, Inc. has announced its 2026 Annual Meeting of Stockholders, set for June 16, 2026, to elect directors, approve an incentive plan, and ratify auditor appointments.

LivaNova PLC has announced its 2026 Annual General Meeting of Shareholders, scheduled for June 10, 2026, to elect directors, approve executive compensation, and ratify auditor appointments.

Encore Capital Group, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 12, 2026, to elect directors, approve executive compensation, and ratify auditor appointments.

Compass Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 10, 2026, with a record date of April 15, 2026.

Titan International, Inc. has filed its 2026 Proxy Statement detailing the upcoming Annual Meeting of Stockholders on June 18, 2026, focusing on director elections, auditor ratification, and executive compensation.

Fortive Corporation announced its 2026 Annual Meeting of Shareholders, scheduled for June 9th, with proposals including director elections, executive compensation advisory vote, and auditor ratification.

Genelux Corporation has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, to elect a director and ratify auditor.

Centessa Pharmaceuticals PLC has issued a proxy statement for its 2026 Annual General Meeting, scheduled for June 12, 2026, detailing proposals for director re-appointments, auditor ratification, and adoption of financial reports.

Celldex Therapeutics announces its 2026 Annual Meeting of Stockholders, scheduled for June 25, 2026, to elect directors, ratify auditors, and approve equity plan amendments.

Marblegate Capital Corporation has issued a proxy statement detailing the agenda for its 2026 Annual Meeting of Stockholders, including director elections and equity plan adoption.

Legence Corp. has announced its 2026 Annual Meeting of Stockholders, highlighting a strong 2025 performance post-IPO and a positive outlook for the upcoming year.

908 Devices Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to be held virtually.

C4 Therapeutics announces its 2026 Annual Meeting of Stockholders, set for June 24, 2026, to elect directors, vote on executive compensation, ratify auditors, and approve a plan amendment.

United Therapeutics Corporation has released its 2026 Proxy Statement, detailing proposals for the upcoming Annual Meeting of Shareholders, including director elections, executive compensation, and stock incentive plans.

Massimo Group announces its 2026 Annual Meeting of Stockholders, to be held virtually on May 27, 2026, with key proposals including director elections and executive compensation.

Sidus Space, Inc. has filed its proxy statement for the 2026 Annual Meeting of Stockholders to be held on June 18, 2026.

LM Funding America seeks shareholder approval for a reverse stock split and the issuance of shares related to 2025 financing.

TXNM Energy shareholders will vote on director elections, auditor ratification, and executive compensation ahead of the expected 2026 merger with Blackstone Infrastructure.

AST SpaceMobile, Inc. has issued its 2026 Proxy Statement detailing director elections, executive compensation, and the ratification of its independent auditor.

EWSB Bancorp, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting of stockholders scheduled for June 4, 2026.

Disc Medicine, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation advisory votes.

Xilio Therapeutics has filed its 2026 proxy statement, seeking stockholder approval for director elections, auditor ratification, and an amendment to its 2021 Stock Incentive Plan.

Hepion Pharmaceuticals has issued its 2026 proxy statement detailing director elections, auditor ratification, and a significant expansion of its equity incentive plan.